Stanton, L., Saunders, G., Barrans, S., Caddy, J., McLaughlin, K., McKay, P., Zhelyazkova, A., Collins, G., Fox, C., Wilson, J., Morgan-Fox, A., Raftery, J., Richardson-Abraham, J., Seymour, O., Mansell, K., Mell, T., Hoppe, M. V., Serra, A., Griffiths, G., Warbey, V., Radhakrishnan, V., Mozgunov, P., Barrington, S., Burton, C., Johnson, P., Davies, A. (2025). Randomised Phase II study of acalabrutinib in combination with R-CHOP treatment for diffuse large B-cell lymphoma confirms safety and unimpaired treatment delivery. Blood. https://doi.org/10.1182/blood-2025-5459